Annual CFO
-$707.00 K
+$194.00 K+21.53%
31 December 2023
Summary:
XTL Biopharmaceuticals annual cash flow from operations is currently -$707.00 thousand, with the most recent change of +$194.00 thousand (+21.53%) on 31 December 2023. During the last 3 years, it has risen by +$143.00 thousand (+16.82%). XTLB annual CFO is now at all-time high.XTLB Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
N/A
31 March 2024
Summary:
XTL Biopharmaceuticals quarterly cash flow from operations is not available.XTLB Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
N/A
31 March 2024
Summary:
XTL Biopharmaceuticals TTM cash flow from operations is not available.XTLB TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XTLB Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +21.5% | - | - |
| 3 y3 years | +16.8% | - | - |
| 5 y5 years | +13.4% | - | - |
XTLB Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +32.6% | ||||
| 5 y | 5 years | at high | +32.6% | ||||
| alltime | all time | at high | +96.7% |
XTL Biopharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$707.00 K(-21.5%) | - | - |
| Dec 2022 | -$901.00 K(-14.1%) | - | - |
| Dec 2021 | -$1.05 M(+23.4%) | - | - |
| Dec 2020 | -$850.00 K(-6.4%) | - | - |
| Dec 2019 | -$908.00 K(+11.3%) | - | - |
| Dec 2018 | -$816.00 K(-27.5%) | - | - |
| Dec 2017 | -$1.13 M(-35.0%) | - | - |
| Dec 2016 | -$1.73 M(-6.9%) | - | - |
| Dec 2015 | -$1.86 M(-24.7%) | - | - |
| Dec 2014 | -$2.47 M(-1.2%) | -$674.00 K(+48.1%) | -$2.47 M(+6.6%) |
| Sept 2014 | - | -$455.00 K(-16.4%) | -$2.32 M(-11.6%) |
| June 2014 | - | -$544.00 K(-31.7%) | -$2.62 M(-4.5%) |
| Mar 2014 | - | -$797.00 K(+53.3%) | -$2.74 M(+9.8%) |
| Dec 2013 | -$2.50 M(+65.9%) | -$520.00 K(-31.4%) | -$2.50 M(+4.7%) |
| Sept 2013 | - | -$758.00 K(+13.5%) | -$2.39 M(+13.7%) |
| June 2013 | - | -$668.00 K(+20.8%) | -$2.10 M(+18.2%) |
| Mar 2013 | - | -$553.00 K(+35.5%) | -$1.78 M(+17.9%) |
| Dec 2012 | -$1.51 M | -$408.00 K(-13.4%) | -$1.51 M(+73.1%) |
| Sept 2012 | - | -$471.00 K(+36.9%) | -$870.00 K(+34.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2012 | - | -$344.00 K(+21.6%) | -$645.00 K(-45.6%) |
| Mar 2012 | - | -$283.00 K(-224.1%) | -$1.19 M(-9.6%) |
| Dec 2011 | -$1.31 M(-47.3%) | $228.00 K(-192.7%) | -$1.31 M(-14.8%) |
| Sept 2011 | - | -$246.00 K(-72.2%) | -$1.54 M(+2.5%) |
| June 2011 | - | -$885.00 K(+116.4%) | -$1.50 M(+106.7%) |
| Mar 2011 | - | -$409.00 K(+95.7%) | -$727.00 K(+6.8%) |
| Sept 2010 | - | -$209.00 K(+91.7%) | -$681.00 K(-3.7%) |
| June 2010 | - | -$109.00 K(-19.3%) | -$707.00 K(-0.7%) |
| Mar 2010 | - | -$135.00 K(-40.8%) | -$712.00 K(-71.4%) |
| Dec 2009 | -$2.49 M(-76.5%) | -$228.00 K(-3.0%) | -$2.49 M(+10.1%) |
| Sept 2009 | - | -$235.00 K(+106.1%) | -$2.26 M(+11.6%) |
| June 2009 | - | -$114.00 K(-94.0%) | -$2.02 M(+6.0%) |
| Mar 2009 | - | -$1.91 M | -$1.91 M |
| Dec 2008 | -$10.58 M(-50.7%) | - | - |
| Dec 2007 | -$21.46 M(+70.5%) | - | - |
| Dec 2006 | -$12.59 M(+20.3%) | - | - |
| Dec 2005 | -$10.47 M(-27.8%) | - | - |
| Dec 2004 | -$14.49 M(+8.8%) | - | - |
| Dec 2003 | -$13.33 M | - | - |
FAQ
- What is XTL Biopharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals annual CFO year-on-year change?
- What is the all time high quarterly CFO for XTL Biopharmaceuticals?
- What is the all time high TTM CFO for XTL Biopharmaceuticals?
What is XTL Biopharmaceuticals annual cash flow from operations?
The current annual CFO of XTLB is -$707.00 K
What is the all time high annual CFO for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high annual cash flow from operations is -$707.00 K
What is XTL Biopharmaceuticals annual CFO year-on-year change?
Over the past year, XTLB annual cash flow from operations has changed by +$194.00 K (+21.53%)
What is the all time high quarterly CFO for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high quarterly cash flow from operations is $228.00 K
What is the all time high TTM CFO for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high TTM cash flow from operations is -$645.00 K